- Home
- INKT vs BLUE Comparison
INKT vs BLUE Comparison
Compare INKT & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- BLUE
- Stock Information
- Founded
- INKT 2017
- BLUE 1992
- Country
- INKT United States
- BLUE United States
- Employees
- INKT N/A
- BLUE N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INKT Health Care
- BLUE Health Care
- Exchange
- INKT Nasdaq
- BLUE Nasdaq
- Market Cap
- INKT 31.2M
- BLUE 36.9M
- IPO Year
- INKT 2021
- BLUE 2013
- Fundamental
- Price
- INKT $7.03
- BLUE $3.50
- Analyst Decision
- INKT Strong Buy
- BLUE Hold
- Analyst Count
- INKT 2
- BLUE 7
- Target Price
- INKT $37.50
- BLUE $44.60
- AVG Volume (30 Days)
- INKT 2.8K
- BLUE 160.2K
- Earning Date
- INKT 05-15-2025
- BLUE 05-20-2025
- Dividend Yield
- INKT N/A
- BLUE N/A
- EPS Growth
- INKT N/A
- BLUE N/A
- EPS
- INKT N/A
- BLUE N/A
- Revenue
- INKT N/A
- BLUE $83,807,000.00
- Revenue This Year
- INKT N/A
- BLUE $218.58
- Revenue Next Year
- INKT N/A
- BLUE N/A
- P/E Ratio
- INKT N/A
- BLUE N/A
- Revenue Growth
- INKT N/A
- BLUE 184.12
- 52 Week Low
- INKT $4.56
- BLUE $3.56
- 52 Week High
- INKT $13.79
- BLUE $28.60
- Technical
- Relative Strength Index (RSI)
- INKT 39.71
- BLUE 32.56
- Support Level
- INKT $7.20
- BLUE $3.62
- Resistance Level
- INKT $7.40
- BLUE $4.45
- Average True Range (ATR)
- INKT 0.39
- BLUE 0.25
- MACD
- INKT -0.02
- BLUE -0.05
- Stochastic Oscillator
- INKT 27.41
- BLUE 1.83
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.